Avanzar Pharmaceutical Private Limited
About Avanzar Pharmaceutical Private Limited
Data last updated:
Avanzar Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC301493. Its GSTIN is 09AAOCA4879Q1ZI (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shriom Gupta and Ritu Soti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24/359 New Moti Nagar, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.64 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹69,679 (net margin -10.5%) and EBITDA of -₹69,219 (EBITDA margin -10.4%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 40% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address24/359 New Moti Nagar, New Delhi, Delhi, India – 110015
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Avanzar Pharmaceutical Private Limited
The main business activity of Avanzar Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Avanzar Pharmaceutical Private Limited FY 2025 filings available
Avanzar Pharmaceutical Private Limited reported revenue of ₹6.64 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Avanzar Pharmaceutical Private Limited
Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 40%. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Avanzar Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹69,219 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹69,679 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Avanzar Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -10.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avanzar Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shriom Gupta | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
| Ritu Soti | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
| Hari Prasad Gaur | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
| Kuldip Kaur | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
Peer Comparison of Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rocket Sewa Private Limited | ₹6.71 Lakh (FY 2023) | •••• | •••• | 47.0% | •••• | Mzn, Uttar Pradesh, India |
| Roshni Health Care Private Limited | ₹6.7 Lakh (FY 2022) | •••• | •••• | -52.0% | •••• | Pune, Maharashtra, India |
| Carekart Cure at Home Private Limited | ₹6.67 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Jaipur, Rajasthan, India |
| MJ Multispeciality Hospicare Private Limited | ₹6.66 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Bhubaneswar, Odisha, India |
| Dr GPS Medicare Private Limited | ₹6.64 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Jaunpur, Uttar Pradesh, India |
| Avanzar Pharmaceutical Private Limited this company | ₹6.64 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
| Zilfur Pharma Private Limited | ₹6.63 Lakh (FY 2022) | •••• | •••• | -23.0% | •••• | Pune, Maharashtra, India |
| Deepfacts Private Limited | ₹6.62 Lakh (FY 2024) | •••• | •••• | 66.0% | •••• | Hyderabad, Telangana, India |
| Ratan Dularo Hospital Private Limited | ₹6.6 Lakh (FY 2019) | •••• | •••• | •••• | Etah, Uttar Pradesh, India | |
| Wayzina Pharmaceuticals Private Limited | ₹6.58 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Patna, Bihar, India |
| Sabra Medicare Private Limited | ₹6.58 Lakh (FY 2025) | •••• | •••• | 168.0% | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Avanzar Pharmaceutical by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Avanzar Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Avanzar Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Avanzar Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Hari Prasad Gaur was appointed as Director on 16 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Avanzar Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Avanzar Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avanzar Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAOCA4879Q1ZI | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avanzar Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avanzar Pharmaceutical Private Limited
Avanzar Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 June 2016 (10+ years old) and is registered under CIN U74999DL2016PTC301493.
Avanzar Pharmaceutical reported revenue of ₹6.64 Lakh for FY 2025 (up 32% YoY).
Avanzar Pharmaceutical has 4 current directors:
- Shriom Gupta - Director
- Ritu Soti - Director
- Hari Prasad Gaur - Director
- Kuldip Kaur - Director
Avanzar Pharmaceutical reported a net loss of ₹69,679 (net margin -10.5%) and EBITDA of -₹69,219 (EBITDA margin -10.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Avanzar Pharmaceutical is 7% over three years and -40% over five years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Avanzar Pharmaceutical is 09AAOCA4879Q1ZI, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Avanzar Pharmaceutical is U74999DL2016PTC301493. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avanzar Pharmaceutical was incorporated on 16 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Avanzar Pharmaceutical by revenue are Rocket Sewa Private Limited, Roshni Health Care Private Limited, Carekart Cure at Home Private Limited, MJ Multispeciality Hospicare Private Limited, Dr GPS Medicare Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Hari Prasad Gaur was appointed as Director on 16 Jun 2016. Kuldip Kaur was appointed as Director on 16 Jun 2016. Ritu Soti was appointed as Director on 16 Jun 2016. Avanzar Pharmaceutical has 4 board changes on record in total.
The registered office of Avanzar Pharmaceutical is at 24359 New Moti Nagar, New Delhi, Delhi, India – 110015.